Top

Clinical Rheumatology

Published in:

28-07-2022 | Rheumatoid Arthritis | Original Article

Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population

Authors: Shanshan Liu, Ju Li, Yongsheng Li, Yan Liu, Kai Wang, Wenyou Pan

Published in: Clinical Rheumatology | Issue 11/2022

Abstract

Objective

C-reactive protein (CRP) is an important index for evaluating the disease activity of rheumatoid arthritis (RA). CRP may play a direct role in bone destruction in RA. Studies have demonstrated that serum CRP levels had a close correlation with tissue inflammation scores in patients with RA. In addition, genetic factors play a crucial role in the development of RA. In this study, we aimed to investigate the relationship between the CRP gene variants (rs1205 polymorphism) and the risk of RA in Chinese Han population.

Methods

502 RA patients and 581 controls were included in this study. The associations between CRP gene variants and CRP levels and RA risk were investigated.

Results

We found that TT/ TT + CT genotype was significantly related with an increased risk of RA (TT vs CC: OR, 1.56, 95%CI, 1.01–2.40, P = 0.045; TT + CT vs CC: OR, 1.30, 95%CI, 1.02–1.65, P = 0.032). In addition, T allele was shown to associate with an elevated risk of RA. After subgroup analysis, we found that rs1205 polymorphism was significantly related with an enhanced risk of RA among females, individuals lower than 60 years, and subjects with a BMI > 25 kg/m². Furthermore, data showed that the CRP gene rs1205 polymorphism correlated with CRP and ESR levels. Furthermore, the TT genotype was significantly associated with a reduction of CRP levels compared with CT or CC genotype.

Conclusions

To sum up, this study reveals that rs1205 polymorphism of the CRP gene is related with an increased risk of RA and CRP levels in Chinese Han population.

Key Points

• The CRP gene rs1205 polymorphism is related with a higher risk of RA.

• The CRP gene rs1205 polymorphism correlates with CRP and ESR levels.

• The TT genotype of rs1205 polymorphism is linked with a reduction of CRP levels.

Kaur I, Behl T, Bungau S, Kumar A, Mehta V, Setia D, Uddin MS, Zengin G, Aleya L, Arora S (2020) Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sci 258:118164. https://doi.org/10.1016/j.lfs.2020.118164CrossRefPubMed

Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170(1):ITC1–ITC16. https://doi.org/10.7326/AITC201901010CrossRefPubMed

Jin S, Li M, Fang Y, Li Q, Liu J, Duan X, Liu Y, Wu R, Shi X, Wang Y, Jiang Z, Wang Y, Yu C, Wang Q, Tian X, Zhao Y, Zeng X, Co-authors C (2017) Chinese Registry of rheumatoid arthritis (CREDIT): II Prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. Arthritis Res Ther 19(1):251. https://doi.org/10.1186/s13075-017-1457-zCrossRefPubMedPubMedCentral

Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8CrossRefPubMed

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001. https://doi.org/10.1038/nrdp.2018.1CrossRefPubMed

McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389(10086):2328–2337. https://doi.org/10.1016/S0140-6736(17)31472-1CrossRefPubMed

Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K (2019) Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis 78(4):446–453. https://doi.org/10.1136/annrheumdis-2018-213678CrossRefPubMed

Traylor M, Curtis C, Patel H, Breen G, Hyuck Lee S, Xu X, Newhouse S, Dobson R, Steer S, Cope AP, Markus HS, Lewis CM, Scott IC (2017) Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case-control study. Rheumatology (Oxford) 56(8):1282–1292. https://doi.org/10.1093/rheumatology/kex048CrossRef

Leng RX, Di DS, Ni J, Wu XX, Zhang LL, Wang XF, Liu RS, Huang Q, Fan YG, Pan HF, Wang B, Ye DQ (2020) Identification of new susceptibility loci associated with rheumatoid arthritis. Ann Rheum Dis 79(12):1565–1571. https://doi.org/10.1136/annrheumdis-2020-217351CrossRefPubMed

10.

Kwon YC, Lim J, Bang SY, Ha E, Hwang MY, Yoon K, Choe JY, Yoo DH, Lee SS, Lee J, Chung WT, Kim TH, Sung YK, Shim SC, Choi CB, Jun JB, Kang YM, Shin JM, Lee YK, Cho SK, Kim BJ, Lee HS, Kim K, Bae SC (2020) Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis. Ann Rheum Dis 79(11):1438–1445. https://doi.org/10.1136/annrheumdis-2020-217663CrossRefPubMed

11.

Saxena R, Plenge RM, Bjonnes AC, Dashti HS, Okada Y, Gad El Haq W, Hammoudeh M, Al Emadi S, Masri BK, Halabi H, Badsha H, Uthman IW, Margolin L, Gupta N, Mahfoud ZR, Kapiri M, Dargham SR, Aranki G, Kazkaz LA, Arayssi T (2017) A multinational Arab genome-wide association study identifies new genetic associations for rheumatoid arthritis. Arthritis Rheumatol 69(5):976–985. https://doi.org/10.1002/art.40051CrossRefPubMed

12.

Rhodes B, Furnrohr BG, Vyse TJ (2011) C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 7(5):282–289. https://doi.org/10.1038/nrrheum.2011.37CrossRefPubMed

13.

Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812. https://doi.org/10.1172/JCI18921CrossRefPubMedPubMedCentral

14.

Yao Z, Zhang Y, Wu H (2019) Regulation of C-reactive protein conformation in inflammation. Inflamm Res 68(10):815–823. https://doi.org/10.1007/s00011-019-01269-1CrossRefPubMed

15.

Shimada K, Komiya A, Yokogawa N, Nishino J, Sugii S, Tohma S (2017) Impact of the size and number of swollen joints on serum C-reactive protein level and erythrocyte sedimentation rate in rheumatoid arthritis: a cross-sectional study in Japan. Clin Rheumatol 36(2):427–431. https://doi.org/10.1007/s10067-016-3482-8CrossRefPubMed

16.

Pope JE, Choy EH (2021) C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum 51(1):219–229. https://doi.org/10.1016/j.semarthrit.2020.11.005CrossRefPubMed

17.

Shafran IH, Alasti F, Smolen JS, Aletaha D (2020) Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab. Ann Rheum Dis 79(7):874–882. https://doi.org/10.1136/annrheumdis-2019-215987CrossRefPubMed

18.

Delongui F, Lozovoy MAB, Iriyoda TMV, Costa NT, Stadtlober NP, Alfieri DF, Flauzino T, Dichi I, Simao ANC, Reiche EMV (2017) C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels. Clin Rheumatol 36(8):1779–1788. https://doi.org/10.1007/s10067-017-3695-5CrossRefPubMed

19.

Ammitzboll CG, Steffensen R, Bogsted M, Horslev-Petersen K, Hetland ML, Junker P, Johansen JS, Podenphant J, Ostergaard M, Ellingsen T, Stengaard-Pedersen K (2014) CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients. Arthritis Res Ther 16(5):475. https://doi.org/10.1186/s13075-014-0475-3CrossRefPubMedPubMedCentral

20.

Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, Steer S, Merriman TR, Vyse TJ (2010) A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 7(9):e1000341. https://doi.org/10.1371/journal.pmed.1000341CrossRefPubMedPubMedCentral

21.

Plant D, Ibrahim I, Lunt M, Eyre S, Flynn E, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Bragggss BA (2012) Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Res Ther 14(5):R214. https://doi.org/10.1186/ar4052CrossRefPubMedPubMedCentral

22.

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588. https://doi.org/10.1136/ard.2010.138461CrossRefPubMed

23.

Wipff J, Dieude P, Avouac J, Hachulla E, Cracowski JL, Diot E, Mouthon L, Sibilia J, Tiev K, Meyer O, Kahan A, Boileau C, Allanore Y (2014) Association study of CRP gene in systemic sclerosis in European Caucasian population. Rheumatol Int 34(3):389–392. https://doi.org/10.1007/s00296-013-2673-8CrossRefPubMed

24.

Cheng Y, Dang A, Lv N, Gao Q, Chen B, Liu G (2016) Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis. Clin Rheumatol 35(3):673–678. https://doi.org/10.1007/s10067-014-2674-3CrossRefPubMed

25.

Nair AM, Goel R, Hindhumati M, Shah K, Chandana P, Jayaseelan V, Jayakanthan K, Joseph G, Danda S, Danda D (2018) C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: associations and phenotype correlations. Int J Rheum Dis 21(3):732–739. https://doi.org/10.1111/1756-185X.13180CrossRefPubMed

26.

Atisha-Fregoso Y, Lima G, Carrillo-Maravilla E, Posadas-Sanchez R, Perez-Hernandez N, Banos-Pelaez M, Iturralde-Chavez A, Hernandez-Diaz N, Jakez-Ocampo J, Rodriguez-Perez JM, Vargas-Alarcon G, Llorente L, Romero-Diaz J (2018) C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population. Clin Rheumatol 37(7):1817–1824. https://doi.org/10.1007/s10067-018-4059-5CrossRefPubMed

27.

Enocsson H, Sjowall C, Kastbom A, Skogh T, Eloranta ML, Ronnblom L, Wettero J (2014) Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-alpha and a C-reactive protein gene variant. Arthritis Rheumatol 66(6):1568–1573. https://doi.org/10.1002/art.38408CrossRefPubMed

28.

Danila MI, Westfall AO, Raman K, Chen L, Reynolds RJ, Hughes LB, Arnett DK, McGwin G, Szalai AJ, van der Heijde DM, Conn D, Callahan LF, Moreland LW, Bridges SL Jr (2015) The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis. Genes Immun 16(7):446–451. https://doi.org/10.1038/gene.2015.24CrossRefPubMedPubMedCentral

Title: Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population
Authors: Shanshan Liu
Ju Li
Yongsheng Li
Yan Liu
Kai Wang
Wenyou Pan
Publication date: 28-07-2022
Publisher: Springer International Publishing
Keyword: Rheumatoid Arthritis
Published in: Clinical Rheumatology / Issue 11/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-022-06306-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2022

Kikuchi Fujimoto disease as the presenting component of VEXAS syndrome: a case report of a probable association

Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: a case series and literature review

Analyzing the gene regulatory network in hepatitis B patients by single-cell ATAC sequencing

Autoimmune/autoinflammatory syndrome induced by adjuvants: a focus on silicone

Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study

Correction to: Immunoglobulin G4–related coronary periarteritis: a systematic literature review with a case series

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials